These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 31252171)

  • 1. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
    Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
    Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.
    Tang J; Wang J; Fan L; Li X; Liu N; Luo W; Wang J; Wang Y; Wang Y
    Oncotarget; 2016 Apr; 7(17):24050-62. PubMed ID: 26992227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
    Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
    Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-angiogenic and anti-vasculogenic mimicry effects of GN25 in endothelial and glioma cells.
    Wen ZH; Chang L; Yang SN; Yu CL; Tung FY; Kuo HM; Lu IC; Wu CY; Shih PC; Chen WF; Chen NF
    Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119799. PubMed ID: 39043304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-anti-angiogenesis nanoparticles enhance anti-metastatic-tumor efficacy of chemotherapeutics.
    Luo J; Zhong X; Peng Y; Hao C; Liang X; Yang Y; Shi X; Chen X; Yi X; Li X; Wu J; Li J; Xiao Q; Wu C; Lu R; Pan Y; Wang X; Fan JB; Wang Y; Wang Y
    Bioact Mater; 2022 Jul; 13():179-190. PubMed ID: 35224300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.
    Feng X; Yao J; Gao X; Jing Y; Kang T; Jiang D; Jiang T; Feng J; Zhu Q; Jiang X; Chen J
    ACS Appl Mater Interfaces; 2015 Dec; 7(50):27885-99. PubMed ID: 26619329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
    Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer.
    Lim D; Do Y; Kwon BS; Chang W; Lee MS; Kim J; Cho JG
    BMB Rep; 2020 Jun; 53(6):291-298. PubMed ID: 32438972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
    Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer.
    Liu S; Ni C; Zhang D; Sun H; Dong X; Che N; Liang X; Chen C; Liu F; Bai J; Lin X; Zhao X; Sun B
    Cell Death Dis; 2019 Feb; 10(3):200. PubMed ID: 30814488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo.
    Jang C; Lee JH; Sahu A; Tae G
    Nanoscale; 2015 Nov; 7(44):18584-94. PubMed ID: 26489965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer.
    Wang J; Wang C; Li Y; Li M; Zhu T; Shen Z; Wang H; Lv W; Wang X; Cheng X; Xie X
    Clin Transl Med; 2021 May; 11(5):e425. PubMed ID: 34047469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.
    Wang Y; Liu P; Duan Y; Yin X; Wang Q; Liu X; Wang X; Zhou J; Wang W; Qiu L; Di W
    Biomaterials; 2014 Jan; 35(3):983-92. PubMed ID: 24176193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.
    Xiao X; Yang M; Xiao J; Zou J; Huang Q; Yang K; Zhang B; Yang F; Liu S; Wang H; Bai P
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):807-18. PubMed ID: 24638862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
    Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
    Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
    Zheng N; Zhang S; Wu W; Zhang N; Wang J
    Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
    Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
    J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.